Defining high risk in the cardiovascular-kidney-metabolic syndrome and associated cardiovascular disease outcomes

Back

ESC Professional Premium Access

Defining high risk in the cardiovascular-kidney-metabolic syndrome and associated cardiovascular disease outcomes

Session: Metabolic syndrome and heart disease (1)

Topic: Cardiovascular Risk Assessment

Speaker: Doctor N. Shah (Chicago, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Nilay Shah

Northwestern University Feinberg School of Medicine, Chicago (United States of America)

0 follower

5 more presentations in this session

High-Intensity interval training improves global longitudinal strain in patients with metabolic syndrome and high risk of heart failure

Speaker: Doctor E. Garcia Camacho (Toledo, ES)

Genetic predisposition of metabolic syndrome independent of weight in premature atherosclerosis

Speaker: Doctor S. Singh (Amsterdam, NL)

The triglyceride-glucose index is a predictor for cardiovascular events and all-cause mortality in young and middle-aged patients with metabolic syndrome

Speaker: Doctor W. Chen (Beijing, CN)

Estimated pulse wave velocity as a forefront indicator of developing metabolic syndrome

Speaker: Associate Professor H. Kim (Guri, KR)

A new natural product derived from cyclosorus terminans provides cardiometabolic protection against obese-induced cardiac dysfunction in rats via suppressing mitochondrial dysfunctions and apoptosis

Speaker: Doctor C. Maneechote (Chiang Mai, TH)

Access the full session

Metabolic syndrome and heart disease (1)

Speakers: Doctor N. Shah, Doctor E. Garcia Camacho, Doctor S. Singh, Doctor W. Chen, Associate Professor H. Kim...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources